22nd Century Presents at Hofstra Northwell School of Medicine; Reveals New Initiative to Engage Health Care Professionals Biotech Investing
EnWave Announces First Quarterly Positive Net Income and Reports Consolidated Interim Financial Results for the Second Quarter Fiscal Year 2016 Biotech Investing
PharmaCyte Biotech to Present Clinical Trial at Marcum MicroCap, ASCO and BIO International Conferences Biotech Investing
Nano Dimension and Accellta Joined Forces to Successfully BioPrint Stem Cell-Derived Tissues Emerging Technology Investing
Independent Phase II and III Clinical Studies on 22nd Century's Smoking Cessation Technology Highlighted on New Heracles Website Biotech Investing
PharmaCyte Biotech to Engage Principal Investigator for Clinical Trial in Pancreatic Cancer Biotech Investing
Initial Efficacy Data for GlycoMimetics’ GMI-1271 Combined with Chemotherapy in Patients with AML to Be Presented at European Hematology Association 21st Congress Biotech Investing
Fortress Biotech Presents Positive Data from the Phase 1/2 Study of CNDO-109-Activated Allogeneic Natural Killer Cells in Acute Myeloid Leukemia at the Innate Killer Summit 2016 Biotech Investing
